http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100791194-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate | 2006-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100791194-B1 |
| titleOfInvention | Sustained-release pellets for oral administration of venlafaxine hydrochloride and preparation method thereof |
| abstract | The present invention relates to a sustained release pellet for oral administration of venlafaxine hydrochloride and a method for producing the same. In the present invention, there is provided a sustained-release pellet of venlafaxine hydrochloride, in which a secondary emission control layer and a tertiary release control layer are sequentially formed on a core, followed by a primary release control layer containing a drug, and a method of preparing the same. Venlafaxine hydrochloride sustained release pellets of the present invention, the primary, secondary, and tertiary release-controlling layer triple the release of the drug to control the dissolution rate is uniform, stable and the dissolution rate can be adjusted to the desired form. In addition, according to the present invention, since the whole process of pellet production is carried out in a fluidized bed granulator, which is a single machine, it is possible to obtain precise sustained-release particles having a uniform particle size distribution and uniform content even though the manufacturing process is simple and the manufacturing time is shortened. have.n n n n Venlafaxine Hydrochloride, Sustained Release, Pellets, Oral, Triple Control |
| priorityDate | 2006-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.